BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32539768)

  • 1. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
    BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma.
    Wang J; Qiu Y; Yang Y; Shen S; Zhi M; Zhang B; Wang W
    Cancer Med; 2022 Oct; 11(19):3633-3642. PubMed ID: 35415945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatectomy is associated with survival in intrahepatic cholangiocarcinoma: An observational study by instrumental variable analysis.
    Chen W; Wu Z; Cao L
    Medicine (Baltimore); 2021 Mar; 100(9):e24147. PubMed ID: 33655908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
    Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
    HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.
    Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F
    Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis.
    Fu J; Chen Q; Yu Y; You W; Ding Z; Gao Y; Li H; Zeng Y
    Cancer Med; 2021 Oct; 10(20):6985-6997. PubMed ID: 34405567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
    Deng L; Wang Y; Zhao J; Tong Y; Zhang S; Jin C; Chen K; Bao W; Yu Z; Chen G
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):603-612. PubMed ID: 32933804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific metastases of intrahepatic cholangiocarcinoma and its impact on survival: a population-based study.
    Yan X; Wang P; Zhu Z; Ning Z; Xu L; Zhuang L; Sheng J; Meng Z
    Future Oncol; 2019 Jun; 15(18):2125-2137. PubMed ID: 31161810
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.
    Chang WW; Hsiao PK; Qin L; Chang CL; Chow JM; Wu SY
    Radiother Oncol; 2018 Nov; 129(2):284-292. PubMed ID: 30279046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
    Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
    Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
    Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
    Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
    Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.
    Chen Z; Pu L; Gao W; Zhang L; Han G; Zhu Q; Li X; Wu J; Wang X
    Oncotarget; 2017 Apr; 8(17):28959-28970. PubMed ID: 28415824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.